Centogene AG-医療機器分野:企業M&A・提携分析

◆英語タイトル:Centogene AG - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011444
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Centogene AG (Centogene) is a provider of genetic testing services. The company offers genetic testing for rare hereditary disorders. It offers whole genome sequencing, whole exome sequencing, biomarker and biochemical testing; prenatal testing, DNA extraction and cell culture services. Centogene provides research programs related to biomarker discovery and utilization, development of new diagnostic techniques, non-interventional and interventional studies. The company also supports clinicians with genetic counseling services and newborn screening. It provides genetic diagnostic testing for rare hereditary diseases. The company operates in Germany, Austria, India and the UAE. Centogene is headquartered in Rostock, Germany.

Centogene AG – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Centogene AG, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Centogene AG, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Centogene AG, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Centogene AG, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Centogene AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Centogene AG, Medical Equipment, Deal Details 11
Venture Financing 11
Centogene Raises USD28 Million in Series A Financing 11
Partnerships 12
Qiagen and Centogene Enter into Co-Marketing Agreement 12
Centogene Forms Joint Venture with ELAJ 13
Centogene Partners with Filgen 14
Centogene Partners with Mikrogen 15
Centogene AG – Key Competitors 16
Centogene AG – Key Employees 17
Centogene AG – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Strategy And Business Planning 19
Aug 28, 2016: CENTOGENE’s new headquarter in Rostock 19
Jan 04, 2016: CENTOGENE/Germany and ELAJ Group/Saudi-Arabia announce strategic partnership in genetic testing services 20
Corporate Communications 21
Jun 09, 2016: Thomas G Klopack appointed as head of CENTOGENE’s US business 21
Mar 18, 2016: CENTOGENE announces the appointment of Dr. Volkmar Weckesser as new Chief Information Officer 22
Jan 06, 2016: Dr. Volkmar Weckesser appointed as new CIO of CENTOGENE 23
Jan 04, 2016: CENTOGENE appoints new CFO, Richard Stoffelen, to take company through next phase of growth 24
Jan 03, 2016: Prof. Peter Bauer and Jochen Pfänder joined the management of CENTOGENE 25
Legal and Regulatory 26
Jan 27, 2017: CENTOGENE successfully renewed accreditation from College of American Pathologists 26
Nov 08, 2016: CENTOGENE received Illumina Propel Certification for Core and Service Labs 27
Product News 28
Apr 24, 2017: CENTOGENE adds extends single gene analyses and NGS panels 28
Jan 16, 2017: CENTOGENE extends its test portfolio 29
Oct 17, 2016: FDNA and Centogene Announce First Grant of Molecular Testing Under the Face2Gene Unknown Forum Grant Program at the American Society of Human Genetics (ASHG) Annual Meeting 30
Sep 28, 2016: CENTOGENE is thrilled to announce the new release of its genomic database CentoMD 3.1 31
Sep 22, 2016: CENTOGENE´s genomic database allows decoding rare genetic information – CentoMD® 3.1 bursts the 100,000 real case line 32
Jul 29, 2016: CentoPortal – Your solution for smarter diagnostics 33
May 23, 2016: CENTOGENE drives CentoMD – the world’s largest mutation data base for rare diseases – to the next level 34
Mar 24, 2016: CentoMD 2.2 – The new release is now available 35
01/05/2016: CentoICU – The comprehensive NGS panel for the early and fast diagnosis of critically ill newborns & children at the intensive care units of hospitals 36
Other Significant Developments 37
May 05, 2017: Another milestone is reached for the new headquarter in Rostock 37
Feb 02, 2017: Centogene: Our new headquarter is growing rapidly 38
Feb 01, 2017: Genetic Associates to collaborate with CENTOGENE for the Australian and New Zealand Markets 39
Jan 06, 2017: Parkinson’s Institute and Clinical Center partners with CENTOGENE to characterize Parkinson’s patients with targeted gene panel 40
Apr 04, 2016: CentoBrief April 2016 :: newly added single gene analyses and NGS panels 41
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42

List of Tables
Centogene AG, Medical Equipment, Key Facts 2
Centogene AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Centogene AG, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Centogene AG, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Centogene AG, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Centogene AG, Deals By Market, 2011 to YTD 2017 9
Centogene AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Centogene Raises USD28 Million in Series A Financing 11
Qiagen and Centogene Enter into Co-Marketing Agreement 12
Centogene Forms Joint Venture with ELAJ 13
Centogene Partners with Filgen 14
Centogene Partners with Mikrogen 15
Centogene AG, Key Competitors 16
Centogene AG, Key Employees 17
Centogene AG, Other Locations 18
Centogene AG, Subsidiaries 18

★海外企業調査レポート[Centogene AG-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ahimsa Industries Limited:企業の戦略・SWOT・財務情報
    Ahimsa Industries Limited - Strategy, SWOT and Corporate Finance Report Summary Ahimsa Industries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Domtar Corporation:企業の戦略・SWOT・財務情報
    Domtar Corporation - Strategy, SWOT and Corporate Finance Report Summary Domtar Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • AGL Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    AGL Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary AGL Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the opera …
  • Elephant Oil Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Elephant Oil Ltd (Elephant Oil) is an oil and gas company. The company provides services such as exploration and production of oil and natural gas. It provides its exploration services in the underexplored areas of West Africa. Elephant Oil holds interest in a production-sharing contract in …
  • PT Lotte Chemical Titan Tbk:企業の戦略・SWOT・財務情報
    PT Lotte Chemical Titan Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Lotte Chemical Titan Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Jefferies Group LLC:企業の戦略・SWOT・財務情報
    Jefferies Group LLC - Strategy, SWOT and Corporate Finance Report Summary Jefferies Group LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Quantum Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Quantum Pharma Ltd (Quantum Pharma), a subsidiary Clinigen Group Plc, is a manufacturer and supplier of unlicensed medicines. The company develops, manufactures, and supplies niche pharmaceutical products. It offers dermatology products, branded generics and vitamins, borderline substances, …
  • Actinogen Medical Ltd (ACW)-製薬・医療分野:企業M&A・提携分析
    Summary Actinogen Medical Ltd (Actinogen), formerly Actinogen Ltd is a biotechnology company that undertakes research in Alzheimer’s disease and other chronic neurodegenerative diseases. The company’s xanamem is a novel drug under development for the treatment of Alzheimer's disease. It develops dru …
  • Proteomics International Laboratories Ltd (PIQ):医療機器:M&Aディール及び事業提携情報
    Summary Proteomics International Laboratories Ltd (Proteomics International) is a medical technology company that discovers new biopharmaceutical drugs. The company harnesses its proprietary proteomics-based technology platform to work in three integrated areas; diagnostics, analytical services and …
  • University of Dundee-製薬・医療分野:企業M&A・提携分析
    Summary University of Dundee (Dundee) is an educational research university that offers a range of undergraduate, postgraduate, postgraduate research degree, distant learning and English language programs. The university offers a wide range of academic and research courses in various disciplines suc …
  • 3-V Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary 3-V Biosciences Inc (3-V Biosciences) is a clinical-stage pharmaceutical company that develops novel therapeutics in metabolic diseases. The company offers TVB-2640, a fatty acid synthase inhibitor used for the treatment of solid tumors, including non-small cell lung cancer (NSCLC), breast c …
  • LGC Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary LGC Ltd (LGC), formerly LGC (Teddington) Ltd is a life sciences measurement and testing company that offers reference materials, genomics solutions and analytical testing products and services. The company’s products comprise DNA extraction instrumentation, DNA extraction kits, Douglas scien …
  • Oil States International, Inc.:企業の戦略・SWOT・財務分析
    Oil States International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Oil States International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Xencor, Inc.:企業のM&A・事業提携・投資動向
    Xencor, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Xencor, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • SaskEnergy Inc:企業の戦略的SWOT分析
    SaskEnergy Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • SM Energy Co (SM):企業の財務・戦略的SWOT分析
    SM Energy Co (SM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Yokogawa Electric Corporation:戦略・SWOT・企業財務分析
    Yokogawa Electric Corporation - Strategy, SWOT and Corporate Finance Report Summary Yokogawa Electric Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Dart Container Corporation:企業の戦略・SWOT・財務分析
    Dart Container Corporation - Strategy, SWOT and Corporate Finance Report Summary Dart Container Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Meiji Seika Pharma Co Ltd:企業のM&A・事業提携・投資動向
    Meiji Seika Pharma Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Meiji Seika Pharma Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • BL&H Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary BL&H Co Ltd (BL&H), a subsidiary of STADA Pharmaceuticals (Asia) Ltd is a drug company that manufactures and markets diagnostic test kits and drugs. The company offers products including aridol bronchial challenge test kit, cetraxal plus ear drop, al-sense amniotic leak test kit, DC bead-dru …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆